Experienced in Multisystem Inflammatory Syndrome in Children (MIS-C)

Ilhami Celik

Kayseri, TR 
Experienced in Multisystem Inflammatory Syndrome in Children (MIS-C)
Kayseri, TR 
OverviewLocationsClinical Research

Overview

Ilhami Celik practices in Kayseri, Turkey. Celik is rated as an Experienced expert by MediFind in the treatment of Multisystem Inflammatory Syndrome in Children (MIS-C). Their top areas of expertise are Severe Acute Respiratory Syndrome (SARS), COVID-19, Pneumonia, and Multisystem Inflammatory Syndrome in Children (MIS-C).

Their clinical research consists of co-authoring 76 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Multisystem Inflammatory Syndrome in Children (MIS-C).

Locations

Kayseri, Turkey
Other Locations
Eskisehir, Turkey
Selcuk, Turkey
Eskishir, Turkey
Tepebasi, 26470, Turkey
Elazig, 23119, Turkey

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Trial For Evaluation of Efficacy and Safety of SARS-CoV-2 Vaccine (Vero Cell), Inactivated
Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Trial For Evaluation of Efficacy and Safety of SARS-CoV-2 Vaccine (Vero Cell), Inactivated
Enrollment Status: Completed
Publish Date: May 24, 2024
Intervention Type: Biological
Study Drug: CoronaVac Vaccine
Study Phase: Phase 3
Open Label, Multi-Center Phase 3 Clinical Trial to Determine Safety, Efficacy, and Immunogenicity of Booster Vaccination Against SARS-CoV-2
Open Label, Multi-Center Phase 3 Clinical Trial to Determine Safety, Efficacy, and Immunogenicity of Booster Vaccination Against SARS-CoV-2
Enrollment Status: Completed
Publish Date: February 29, 2024
Intervention Type: Biological
Study Phase: Phase 3
Efficacy, Immunogenicity, and Safety of the Two-Dose Inactivated COVID-19 Vaccine (TURKOVAC) Versus the Two-Dose CoronaVac (Sinovac) Vaccine in Healthy Subjects: A Randomized, Observer-Blinded, Phase III Clinical Trial
Efficacy, Immunogenicity, and Safety of the Two-Dose Inactivated COVID-19 Vaccine (TURKOVAC) Versus the Two-Dose CoronaVac (Sinovac) Vaccine in Healthy Subjects: A Randomized, Observer-Blinded, Phase III Clinical Trial
Enrollment Status: Completed
Publish Date: February 29, 2024
Intervention Type: Biological
Study Phase: Phase 3
View 2 Less Clinical Trials

76 Total Publications

Autochthonous cases of malaria in central Anatolia.
Autochthonous cases of malaria in central Anatolia.
Journal: Tropical doctor
Published: June 11, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Celik's expertise for a condition
ConditionClose
      View All 11 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile